Mergers & Acquisitions

INVO Bioscience, Inc. (NasdaqCM: INVO)

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of INVO Bioscience, Inc. (the “Company”) (NasdaqCM: INVO) with NAYA Biosciences Inc. Under the terms of the proposed transaction, (subject to the Interim PIPE, post-transaction and prior to the private offering), INVO shareholders will own approximately 12% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.

If you would like to discuss your legal rights regarding the proposed transaction, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or fill out the form on this page.